These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 26813590

  • 1. [Reversal of stemness in multidrug-resistant hepatocellular carcinoma cells by SIS3].
    Yan W, Wen T, Lin S, Liu Z, Yang W, Wu G.
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):731-5. PubMed ID: 26813590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Li Y, Jiang F, Liu Q, Shen J, Wang X, Li Z, Zhang J, Lu X.
    Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
    Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY.
    Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.
    Jia Q, Zhang X, Deng T, Gao J.
    Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193
    [Abstract] [Full Text] [Related]

  • 13. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells.
    Chen Y, Yu D, Zhang H, He H, Zhang C, Zhao W, Shao RG.
    Int J Biol Sci; 2012 Apr; 8(7):992-1004. PubMed ID: 22904667
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
    Yang Z, Zhang L, Ma A, Liu L, Li J, Gu J, Liu Y.
    PLoS One; 2011 Apr; 6(12):e28405. PubMed ID: 22145042
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C, Soritau O, Rus-Ciuca D, Pop T, Todea D, Mosteanu O, Pintea B, Foris V, Susman S, Kacsó G, Irimie A.
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [Abstract] [Full Text] [Related]

  • 20. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.
    Kohga K, Tatsumi T, Takehara T, Tsunematsu H, Shimizu S, Yamamoto M, Sasakawa A, Miyagi T, Hayashi N.
    J Hepatol; 2010 Jun; 52(6):872-9. PubMed ID: 20395004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.